Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: Japan Clear all

382 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20027
20037
20047
20053
200621
200712
200811
200930
201031
201126
201219
201317
201432
201523
201615
201715
20185
201910
202011
202113
20227
202311
202412
20259
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed325
Unknown status21
Recruiting17
Terminated10
Active, not recruiting7
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S81
Eli Lilly and Company39
AstraZeneca38
Boehringer Ingelheim32
Sanofi21
Astellas Pharma Inc20
Tanabe Pharma Corporation20
Takeda15
Kyowa Kirin Co., Ltd.9
Bayer6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2382
Diabetes Mellitus104
Obesity23
Insulin Resistance17
Renal Insufficiency, Chronic16
Overweight15
Hypertension14
Diabetic Nephropathies12
Diabetes Mellitus, Type 110
Glucose Metabolism Disorders8

Trials

Showing 1 to 25 of 382. Each trial links to its page on Pharma Observatory.

282 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.